ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2300

Polymorphisms of Transient Receptor Potential Vanilloid (TRPV) 2 and TRPV3 Gene Polymorphisms Were Associated with Fibromyalgia in a Korean Population

Yi-Rang Yim1, Dong-Jin Park2, Seong-Ho Kim3, Seong-Su Nah4, Ji Hyun Lee5, Seong-Kyu Kim6, Yeon-Ah Lee7, Seung-Jae Hong8, Hyun-Sook Kim9,10, Hye-Soon Lee11, Hyoun-Ah Kim12, Chung-Il Joung13, Sang-Hyon Kim14 and Shin-Seok Lee1, 1Chonnam National University Medical School and Hospital, Gwangju, South Korea, 2Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 3Inje University Haeundae Paik Hospital, Busan, South Korea, 4Soonchunhyang University, College of Medicine, Cheonan, South Korea, 5Internal Medicine, Maryknoll Medical Center, Busan, South Korea, 6Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, 7Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea, 8Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, 9Internal Medicine, College of Medicine, Chosun University, Gwangju, South Korea, 10Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University of Korea, Seoul, South Korea, 11Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 12Ajou University Hospital, Suwon, South Korea, 13Internal Medicine, Konyang University Medical School, Daejeon, South Korea, 14Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Fibromyalgia (FM) is a chronic pain syndrome characterized by lowered pain thresholds and other FM-related symptoms such as fatigue, anxiety and depression. Recent studies have focused on genetic factors that influence pain sensitivity and development of FM. There are emerging evidences that transient receptor potential vanilloid (TRPV) channels have been contributed to pain hypersensitivity. However, whether polymorphisms of TRPV are associated with FM is unknown. The aim of present study was to evaluate association between polymorphisms of TRPV2 and TRPV3 gene and FM susceptibility, and FM symptoms in a Korean population.

Methods: A total of 409 patients with FM and 423 controls were enrolled from 10 medical centers which participated in the Korean nationwide fibromyalgia survey. The alleles and genotypes at 3 positions [rs3813768(C>G), rs8121(C>T) and rs1129235(C>A)] in the TRPV 2 gene and 2 positions [rs7216486 (G>A) and rs395357(C>T)] in the TRPV 3 gene were genotyped from peripheral blood DNA. The associations of TPPV 2 and TRPV3 genes polymorphisms with FM susceptibility and clinical symptoms of FM were assessed.

Results: The frequencies of alleles and genotypes of individual TRPV2 and TRPV3 genes were not significantly associated with susceptibility of FM. However, the GTA haplotype of TRPV2 gene showed protective against fibromyalgia susceptibility after age- and sex adjusted analysis (OR 0.637; 95% CI; 0.418-0.969; P=0.035). Furthermore, SNP rs395357 of TRPV3 was associated with scores of Brief Fatigue Inventory (BFI) (P=0.017) in FM patients. Although haplotypes of TRPV3 did not show different distribution between FM patients and healthy controls, haplotypes of TRPV3 was associated with BFI and the Short Form-36 Health Status Questionnaire (SF-36) physical health summary scores (P=0.036, respectively)

Conclusion: This large-scale study is the first to evaluate association of TRPV gene polymorphisms with fibromyalgia susceptibility and symptom severity of FM. Our results suggested that certain TRPV2 haplotype have a protective role against FM, and also some genotype and haplotype of TRPV3 contribute to fibromyalgia symptoms. Further researches needed to be confirmed.


Disclosure: Y. R. Yim, None; D. J. Park, None; S. H. Kim, None; S. S. Nah, None; J. H. Lee, None; S. K. Kim, None; Y. A. Lee, None; S. J. Hong, None; H. S. Kim, None; H. S. Lee, None; H. A. Kim, None; C. I. Joung, None; S. H. Kim, None; S. S. Lee, None.

To cite this abstract in AMA style:

Yim YR, Park DJ, Kim SH, Nah SS, Lee JH, Kim SK, Lee YA, Hong SJ, Kim HS, Lee HS, Kim HA, Joung CI, Kim SH, Lee SS. Polymorphisms of Transient Receptor Potential Vanilloid (TRPV) 2 and TRPV3 Gene Polymorphisms Were Associated with Fibromyalgia in a Korean Population [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/polymorphisms-of-transient-receptor-potential-vanilloid-trpv-2-and-trpv3-gene-polymorphisms-were-associated-with-fibromyalgia-in-a-korean-population/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polymorphisms-of-transient-receptor-potential-vanilloid-trpv-2-and-trpv3-gene-polymorphisms-were-associated-with-fibromyalgia-in-a-korean-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology